Cargando…
p53: From Fundamental Biology to Clinical Applications in Cancer
SIMPLE SUMMARY: p53 tumour suppressor gene is the most altered in cancer. Several decades of research have established that it is of pivotal importance in prompting neoplastic phenomena, including cancer initiation and progression. However, it has crucial functions for cellular life. Knowledge and a...
Autores principales: | Capuozzo, Maurizio, Santorsola, Mariachiara, Bocchetti, Marco, Perri, Francesco, Cascella, Marco, Granata, Vincenza, Celotto, Venere, Gualillo, Oreste, Cossu, Alessia Maria, Nasti, Guglielmo, Caraglia, Michele, Ottaiano, Alessandro |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9495382/ https://www.ncbi.nlm.nih.gov/pubmed/36138802 http://dx.doi.org/10.3390/biology11091325 |
Ejemplares similares
-
Evolution of Treatment in Advanced Cholangiocarcinoma: Old and New towards Precision Oncology
por: Capuozzo, Maurizio, et al.
Publicado: (2022) -
Hypertension, type 2 diabetes, obesity, and p53 mutations negatively correlate with metastatic colorectal cancer patients’ survival
por: Ottaiano, Alessandro, et al.
Publicado: (2023) -
Tumour Burden Reporting in Phase III Clinical Trials of Metastatic Lung, Breast, and Colorectal Cancers: A Systematic Review
por: Santorsola, Mariachiara, et al.
Publicado: (2022) -
Survival and Toxicities of Metastatic Colorectal Cancer Patients Treated with Regorafenib before TAS-102 or Vice Versa: A Mono-Institutional Real-Practice Study
por: Ottaiano, Alessandro, et al.
Publicado: (2023) -
Metastatic colorectal cancer and type 2 diabetes: prognostic and genetic interactions
por: Ottaiano, Alessandro, et al.
Publicado: (2021)